Inhaler Corticosteroid Device Market Dynamics Influenced by Air Pollution and Growing Awareness of Respiratory Health

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Inhaler Corticosteroid Device Market- (By Steroid Types (Beclomethasone Dipropionate, Budesonide, Fluticasone Inhaler Powder, & Mometasone), By Application (Asthma, COPD (Chronic Obstructive Pulmonary Disease) and Others) By End-user (Hospitals and Clinics, Academic and Research Institutes and Respiratory Care Center)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Inhaler Corticosteroid Device Market is valued at US$ 616.09 Mn in 2023, and it is expected to reach US$ 886.4 Mn by 2031, with a CAGR of 4.6% during the forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2441

Inhaled corticosteroids (ICS) are widely acknowledged as a cornerstone therapy for the management of asthma. The rising prevalence of respiratory conditions, coupled with increasing air pollution levels, has prompted numerous companies to focus on the development of advanced ICS delivery devices, driving growth within this market.

The inhaled corticosteroid device market comprises medical devices engineered to administer corticosteroids directly to the lungs, providing targeted and effective treatment for chronic respiratory disorders, including asthma and chronic obstructive pulmonary disease (COPD). These devices play a critical role in long-term disease management and are available in multiple formats, such as metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers, primarily serving patients who require consistent daily maintenance therapy.

Market growth is further supported by macroeconomic and demographic trends, including an expanding elderly population, heightened awareness of respiratory health, and increasing global healthcare expenditure. Additionally, the escalation of air pollution worldwide is significantly contributing to demand, as a growing number of individuals seek effective solutions for respiratory disease management.

List of Prominent Players in the Inhaler Corticosteroid Device Market:
• Pfizer Inc.
• GlaxoSmithKline plc
• Novartis AG
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Sanofi
• Boehringer Ingelheim International GmbH.
• AstraZeneca
• F. Hoffmann-La Roche Ltd.
• Bristol-Myers Squibb Company
• Amgen Inc.
• Aurobindo Pharma
• Eli Lilly and Company
• Cipla Inc.
• Sumitomo Corporation

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Market Dynamics
Drivers:
The growth of the inhaled corticosteroid (ICS) device market is being primarily driven by the rising global prevalence of asthma, a chronic respiratory condition characterized by airway inflammation and obstruction. ICS devices are increasingly preferred across pediatric and geriatric populations due to their targeted delivery, ease of use, and effectiveness in managing asthma symptoms. Expanding healthcare expenditure is further enhancing healthcare infrastructure, facilitating broader access to ICS therapies. Additionally, initiatives by both public and private sectors to raise awareness about respiratory health, alongside increasing disposable incomes and higher smoking rates, are contributing to market expansion.

Challenges:
Despite favorable growth trends, the ICS device market faces several constraints. The expiration of patents for key branded drugs and the subsequent availability of cost-effective generics may restrain revenue growth. Limited healthcare infrastructure in developing regions, coupled with the relatively high cost of ICS therapies, further hampers market penetration.

Potential adverse effects associated with ICS usage-such as oral thrush, coughing, hoarseness, and throat irritation-may reduce patient adherence. Moreover, healthcare systems' increasing focus on cost-effectiveness impacts procurement decisions, while environmental considerations are prompting manufacturers to develop inhalation devices with eco-friendly materials and low-impact propellants.

Regional Trends:
North America is projected to maintain a leading position in the ICS device market, driven by its advanced healthcare infrastructure, high incidence of chronic respiratory diseases, and strong emphasis on technological innovation. The region's dominance is supported by a large patient population requiring ongoing respiratory care and a favorable regulatory and reimbursement landscape. Continuous research and development efforts, strategic collaborations between industry leaders and academic institutions, and sustained investments in respiratory healthcare solutions are further reinforcing the growth of the ICS device market in North America.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2441

Recent Developments:
• In September 2020, GlaxoSmithKline plc and Innoviva, Inc. announced the U.S. Food and Drug Administration (FDA) approval for a new indication of Trelegy Ellipta. It is also used to treat patients suffering from chronic obstructive pulmonary disease (COPD).
• BreatheSuite is a 2018 startup firm based in St.Johns, Canada. It has developed an integrated inhaler device for medication adherence to manage COPD and asthma.
• CareTRx is a mobile app and sensor offered by Gecko Health for the management of asthma. The device is added to pre-existing inhalers. It aims at assisting patients to better manage their asthma by tracking medication use.

Segmentation of Global Inhaler Corticosteroid Device Market-
Global Inhaler Corticosteroid Device Market- By Steroid Types
• Beclomethasone Dipropionate
• Budesonide
• Fluticasone Inhaler Powder
• Mometasone
Global Inhaler Corticosteroid Device Market- By Application
• Asthma
• COPD (Chronic Obstructive Pulmonary Disease)
• Others
Global Inhaler Corticosteroid Device Market- By End-User
• Hospitals and Clinics
• Academic and Research Institutes
• Respiratory Care Center
Global Inhaler Corticosteroid Device Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/inhaler-corticosteroid-device-market/2441

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.